Back to search

National Technical University of Athens (NTUA)

Ανάπτυξη ευφυούς συστήματος υποστήριξης κλινικής απόφασης για την έγκαιρη διάγνωση και την εξατομικευμένη διαχείριση γυναικών που βρίσκονται σε κίνδυνο ανάπτυξης καρκίνου του μαστού

Abstract

dc:description

Women population screening using mammography has dramatically reduced breast cancer rates worldwide. Nowadays, in many countries, the prevention of breast cancer policy is based on frequent and repeated mammographies, followed by breast ultrasound and, if necessary, by histological examination in the biological material of the biopsy. However, evaluating mammography findings is considered as a difficult process which can be properly performed only by a highly experienced and well-trained medical staff. Subsequently, the interpretation of the findings could be easily influenced by subjective factors and therefore can be prone to diagnostic errors as evidenced in the present study. Breast MRI (Magnetic Resonance Imaging), is a diagnostic practice indicated in cases of high breast density and at the same time, a high-cost examination for healthcare systems. Furthermore, genetic testing that is used to diagnose hereditary breast cancer, represents a small proportion of breast cancers and at the same time it is a high-cost specialized test. Even the most widely used biopsy, Fine Needle Aspirate (FNA), in some cases involves risks and produces false negative results. Considering the aforementioned facts, this study presents the development of AI (Artificial Intelligence) - based models and the creation of a Clinical Decision Support System (CDSS) for the early diagnosis and personalized management of women at risk of developing breast cancer. These models are based on non-invasive medical data collected during daily clinical practice at the Breast Center of the General Hospital "Elena Venizelou", as well as on data from women’s personal medical health records. Therefore, we demonstrate a tool, which, by combining the results of non-invasive and low-cost diagnostic tests and the medical health record, will be easy to use by clinicians on a daily basis and at the same time cost-effective for the health systems. Using feature selection techniques and machine learning tools, we found that the Random Forest (RF) classifier showed the highest values of accuracy (95.9%), sensitivity (96.5 %), NPV (95%), Youden’s index (0.92) και F1 score (0.97), proving to be an effective algorithm in the development of our innovative CDSS. The proposed CDSS aims to be a sustainable and cost-effective solution for national healthcare systems as it can contribute to a significant cost reduction in terms of personalized management of women at risk of developing breast cancer, while achieving a remarkable increase in the validity of diagnosis.

Degree

thesis:*
Grantor dc:publisher
National Technical University of Athens (NTUA)
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tarousi, Marilena
  • Ταρούση, Μαριλένα

Subjects

dc:subject × 25

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52090

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tarousi, Marilena; Ταρούση, Μαριλένα. Ανάπτυξη ευφυούς συστήματος υποστήριξης κλινικής απόφασης για την έγκαιρη διάγνωση και την εξατομικευμένη διαχείριση γυναικών που βρίσκονται σε κίνδυνο ανάπτυξης καρκίνου του μαστού. National Technical University of Athens (NTUA), 2022. http://hdl.handle.net/10442/hedi/52090